Article
Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
Antimicrobial agents and chemotherapy - 1 Aug 2006
Zhang Zhijun, Walker Michelle, Xu Wen, Shim Jae Hoon, Girardet Jean-Luc, Hamatake Robert K, Hong Zhi
Abstract excerpt
Mutations in and around the catalytic site of the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) are associated with resistance to nucleoside RT inhibitors (NRTIs), whereas changes in the hydrophobic pocket of the RT are attributed to nonnucleoside RT inhibitor (NNRTI) resistance. In this study, we report a novel series of nonnucleoside inhibitors of HIV-1, exemplified by VRX-329747 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
